We are committed to improving the lives of those affected by Duchenne through accelerating research, improving care and empowering the community.CureDuchenne’s mission - cure Duchenne muscular dystrophy (DMD). Our venture philanthropy model funds research, early diagnosis, treatment

Core values

- **Global Outreach and Awareness**: CureDuchenne expands its global initiatives, training healthcare professionals and spreading awareness about Duchenne muscular dystrophy, which is crucial for early diagnosis and proper treatment[1].
- **Improvement in Care and Quality of Life**: The organization has significantly improved the quality of life for individuals with Duchenne muscular dystrophy by advancing multidisciplinary care, physical and occupational therapy, and promoting the use of mobility devices to enhance independence[1][3][4].
- **Research and Funding**: CureDuchenne has raised over $50 million for research, education, and care, and has leveraged over $3 billion in follow-on funding from investors and biotech companies. This has led to 18 projects advancing to human clinical trials and the first FDA-approved drug for Duchenne[4][5].
- **Community Support and Empowerment**: The organization provides extensive support to families, caregivers, and patients through education, workshops, webinars, and certified physical therapist programs, which enhances community well-being and empowers those affected by the disease[4][5].